JSM 2011 Online Program
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Activity Details
|
|
|||
| 89 | Sun, 7/31/2011, 4:00 PM - 5:50 PM | CC-D231/232 | |
| Analysis of Survival Data — Contributed Papers | |||
| Biopharmaceutical Section | |||
| Chair(s): Mulugeta Gebregziabher, Medical University of Medical University of South Carolina | |||
| 4:05 PM | Two-Component Mixture Cure Rate Model with Spline-Estimated Nonparametric Components — Lu Wang, Novartis Oncology | ||
| 4:20 PM | Stratified Time-to-Event Trials: Is There a Best Analysis? — Devan V. Mehrotra, Merck Research Laboratories ; Shu-Chih Su, Merck & Co., Inc. ; Xiaoming Li, Merck Research Laboratories | ||
| 4:35 PM | Sample Size Calculation for Proportional Hazards Cure Model — Songfeng Wang, University of South Carolina ; Jiajia Zhang, University of South Carolina ; Wenbin Lu, North Carolina State University | ||
| 4:50 PM | Analysis of a Composite Endpoint Under Different Censoring Schemes for Component Events — Chunlei Ke, Amgen Inc. ; Beiying Ding, Amgen Inc. ; Jianming Wang, Novartis Oncology ; Qi Jiang, Amgen Inc. | ||
| 5:05 PM | Assessing Evaluation-Time Bias in Progression-Free Survival Data Analysis — Chen Hu, University of Michigan ; Kalyanee Viraswami-Appanna, Novartis ; Bharani Bharani-Dharan, Novartis | ||
| 5:20 PM | Floor Discussion | ||
2011 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.